-transparent.png){kind=logo}
1. Pharmacological properties of a new centrally acting muscle relaxant (NC-1200) were tested in isolated muscle preparations. 2. NC-1200 acted as a Ca-blocker in the guinea pig taenia caecum. The pA2-value was 5.67. 3. In the rabbit aorta, NC-1200 competed with serotonin at serotonin receptors and also shifted the concentration response curves of histamine and norepinephrine suggesting the possibility that NC-1200 interacted with histamine and norepinephrine receptors. The pA2-value of NC-1200 against serotonin was 6.02. 4. There was no evidence that NC-1200 interacted with drug-receptors in the muscles except the rabbit aorta. 5. The present results are similar to the previous findings that the properties of serotonin, histamine and norepinephrine receptors in the rabbit aorta were different from those in other muscles.
I Takayanagi, and
F Konno, and
Y Sato, and
H Uno
January 1995,
European journal of pharmacology,
I Takayanagi, and
F Konno, and
Y Sato, and
H Uno
October 1992,
Neuropharmacology,
I Takayanagi, and
F Konno, and
Y Sato, and
H Uno
March 1998,
General pharmacology,
I Takayanagi, and
F Konno, and
Y Sato, and
H Uno
January 2006,
CNS drug reviews,
I Takayanagi, and
F Konno, and
Y Sato, and
H Uno
September 1968,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
I Takayanagi, and
F Konno, and
Y Sato, and
H Uno
November 1970,
Arzneimittel-Forschung,
I Takayanagi, and
F Konno, and
Y Sato, and
H Uno
June 1997,
Arzneimittel-Forschung,
I Takayanagi, and
F Konno, and
Y Sato, and
H Uno
July 1983,
Chemical & pharmaceutical bulletin,
I Takayanagi, and
F Konno, and
Y Sato, and
H Uno
September 1975,
Neuropharmacology,
I Takayanagi, and
F Konno, and
Y Sato, and
H Uno
March 1987,
Arzneimittel-Forschung,
